Formulation and Drug Delivery

J&J and HHS Team Up on Flu Vaccine and Drug R&D

September 20, 2017

Under this partnership, Johnson & Johnson and BARDA will focus on the advanced development of a small-molecule drug and vaccine for the pandemic flu.

Gates Foundation Invests $40 Million in Immunotherapy Collaboration

September 19, 2017

The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases.

FDA Approves Amgen’s Avastin Biosimilar

September 15, 2017

The approval marks the first biosimilar approved in the United States for treating cancers.

EMA Recommends Approval of Herceptin Biosimilar

September 15, 2017

European Medicines Agency’s Committee for Medicinal Products for Human Use grants a positive opinion for the approval of the biosimilar for treating breast cancer.

FDA Panel Votes Unanimously to Approve GSK Shingles Vaccine

September 14, 2017

Shingrix represents a new, possibly better alternative to existing treatments.

Oxford Genetics Opens First US Office

September 12, 2017

The company has extended its presence in the US market to support its growing business in the region.

Merck KGaA Completes $788-Million Divestment of Biosimilars Business

September 07, 2017

Merck KGaA completes the divestment of its biosimilars business as part of its strategy to focus on developing a pipeline of innovator drugs.

FDA Clears Pfizer’s ADC for Leukemia

September 06, 2017

Pfizer’s Mylotarg, an anti-body drug conjugate once voluntarily withdrawn, returns to the market under a new dosing regimen for treating leukemia.

Manufacturing Standards Key to Advancing Cellular and Gene Therapies

September 02, 2017

FDA works with industry on strategies for assuring high-quality regenerative medicines.

Using Simulation to Address Capacity Limitations

September 02, 2017

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.